In a significant number of publications in the field of precancerous lesions and cervical cancer, the expression of the proliferation marker Ki-67, often in combination with other antigens, has been studied using immunohistochemistry or immunocytochemistry [12,28,29,30,31,32]. This evidence concerns the gene MKI67 and cervical carcinoma.